The Vistria Group Leads Recapitalization of Medalogix and Muse Healthcare
The Vistria Group, a Chicago-based investment firm focusing on the healthcare, education and financial services sectors, announced the recapitalization and growth investment in Medalogix and Muse Healthcare, two premier data science and machine learning technology companies focused on the advancement of patient care within home health, palliative and hospice care settings. Medalogix and Muse Healthcare will consolidate under the Medalogix brand to create a new company that leverages each firm’s expertise and technology to improve care quality.
In addition to the fusion of Medalogix and Muse, three of the foremost entities in the home health and hospice sectors are minority investors, including LHC Group, Amedisys Home Health and Hospice and Encompass Health Corp. Combined, the minority investors provide home health or hospice care across 45 states and the quality of their patient care will benefit from leveraging Medalogix clinical decision support capabilities. Medalogix facilitates value-based care and high performing network solutions.
Recommended AI News: Arctic Wolf Joins Microsoft Intelligent Security Association
“We are delighted to partner with The Vistria Group, welcome Muse Healthcare to the Medalogix platform, and are excited for LHC Group to join as another minority equity investor as we advance our commitment to provide high quality clinical-decision support to improve healthcare for patients, their families, and their care providers,” said Elliott Wood, President and CEO of Medalogix. “The Vistria Group shares our vision of providing the best possible solutions to our customers and impacting change in healthcare by ensuring patients can be cared for in their home.”
“Integrating our technology with the Medalogix solution platform allows us to cover the entire care continuum for patients in the home, giving our customers the insights and care guidance to obtain the most appropriate outcomes,” said Tom Maxwell, Chairman and co-founder of Muse Healthcare. Together, we will accelerate the growth of our customers, ensuring they are using data to support every care decision, and appropriately increase the days of care provided in the place where the patient deserves to be: their home.”
Recommended AI News: Flutura Announces Strategic Partnership & Scale Agreement with TechnipFMC
The combined company’s mission is to empower individualized patient care with innovative solutions that transform healthcare. The new entity will be a market leader in both home health and hospice machine learning capabilities, with a focus on providing the right utilization, the identification of hospitalization risk and decline, and the coordination of care between both services lines, as well as other care delivery networks as more patient care moves into the home. The new company’s solutions engage more than a third of all Medicare home health and hospice recipients, including active support for over 325,000 home health and 50,000 hospice beneficiaries per day.
Bryan Mosher, CEO of Muse Healthcare added: “We are thrilled to join forces with Medalogix and integrate our offerings for our customers. This partnership makes complete sense as both companies are working towards improving the patient experience and obtaining the best outcomes.”